Source comparison
How Long Thymosin Alpha-1 Stays in System: [Timing] Comparison
0–2 hours post-injection Peak (100% of injected dose in circulation) TLR9 receptor binding begins Optimal injection timing is morning to align immune activation with circadian T-cell rhythms This is the initiation phase. Peptide triggers the cascade 2–8 hours
This comparison does not assign a generated winner or score.
- 0–2 hours post-injection
- Peak (100% of injected dose in circulation)
- TLR9 receptor binding begins
- Optimal injection timing is morning to align immune activation with circadian T-cell rhythms
- This is the initiation phase. Peptide triggers the cascade
- 2–8 hours post-injection
- 50–6% remaining (beta-phase elimination)
- IL-2 and IL-7 secretion peaks
- No additional dosing needed. The immune response is self-sustaining at this point
- Peptide is clearing but immune signaling is accelerating
- 8–12 hours post-injection
- Below detection threshold (<1% remaining)
- CD4+ T-cell proliferation peaks
- The peptide is gone but the effect it triggered is at maximum intensity
- This is why half-life and activity window diverge
- 24–48 hours post-injection
- Zero measurable peptide
- Sustained T-cell differentiation and cytokine release
- Researchers dosing daily are overlapping cascades. Twice weekly avoids this
- The immune system is still responding to the original dose
- 72+ hours post-injection
- Immune markers return to baseline
- Next dose should occur before 96 hours to prevent activity gap
- This is the natural resolution point